Cargando…
Inhibitors of c-Jun N-terminal kinases—JuNK no more?
The c-Jun N-terminal kinases (JNKs) have been the subject of intense interest since their discovery in the early 1990s. Major research programs have been directed to the screening and/or design of JNK-selective inhibitors and testing their potential as drugs. We begin this review by considering the...
Autores principales: | Bogoyevitch, Marie A., Arthur, Peter G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185448/ https://www.ncbi.nlm.nih.gov/pubmed/17964301 http://dx.doi.org/10.1016/j.bbapap.2007.09.013 |
Ejemplares similares
-
Linking apoptosis to cancer metabolism: Another missing piece of JuNK
por: Papa, Salvatore, et al.
Publicado: (2016) -
Glossogyne tenuifolia (Hsiang-ju) extract suppresses T cell activation by inhibiting activation of c-Jun N-terminal kinase
por: Houng, Jer-Yiing, et al.
Publicado: (2017) -
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
por: Duong, Men Thi Hoai, et al.
Publicado: (2020) -
c-Jun N-Terminal Kinase Signaling Inhibitors Under Development
por: Han, Sun-Young
Publicado: (2008) -
C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
por: Meyerowitz, Jodi, et al.
Publicado: (2011)